Vectibix 400 MG/20 ML vial 20ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9LZ9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $46,906
Award facts
- Contract value 100% obligated
- $46,905.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $46,905.92 to AmerisourceBergen Drug Corp for the supply of Vectibix (panitumumab) 400 mg/20 mL vials. This firm fixed-price contract was competitively awarded without set-aside designation and is scheduled for completion by January 21, 2026. The award represents a task order executed under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This primary IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, and medical devices, to support military healthcare programs globally.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. The company's fulfillment of this Vectibix order supports DLA's pharmaceutical supply chain operations, which serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The delivery order exemplifies the company's established capability to meet federal procurement requirements for specialized oncology medications through open competition and demonstrates the continued reliance on AmerisourceBergen as a critical vendor for essential pharmaceutical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F9LZ9?
SPE2DR26F9LZ9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F9LZ9 worth?
The government has obligated $46,906 on SPE2DR26F9LZ9.
Is contract SPE2DR26F9LZ9 an order under another contract?
Yes. SPE2DR26F9LZ9 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9LZ9 competed?
The extent of competition for SPE2DR26F9LZ9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award